Krystal Biotech Inc (KRYS) — Capital Reinvestment Ratio
Krystal Biotech Inc (KRYS) has a Capital Reinvestment Ratio of 0.05x as of June 2026, meaning it reinvests 0% of its operating cash flow ($74.79 Million) in capital expenditures ($3.56 Million). Check Krystal Biotech Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Krystal Biotech Inc Capital Reinvestment Ratio (2024–2025)
This chart tracks Krystal Biotech Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Krystal Biotech Inc cash flow conversion.
Annual Capital Reinvestment Ratio for Krystal Biotech Inc (2024–2025)
Year-by-year Capital Reinvestment Ratio for Krystal Biotech Inc from 2024 to 2025. See Krystal Biotech Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | $200.87 Million | $11.95 Million | ▲ +73.3% |
| 2024 | 0.03x | $123.42 Million | $4.24 Million | — |